Dual Action Pain Relief Tablet
Product Images NDC 11673-924

2 FDA label images from Target Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dual Action Pain Relief (NDC 11673-924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

716r_target Ibupara 72ct_lbl (716r Target Ibupara 72ct Lbl)

716r_target Ibupara 72ct_lbl (716r Target Ibupara 72ct Lbl)
Dual Action Pain Relief tablets containing 250 mg ibuprofen and 125 mg acetaminophen in oral tablet form. The label highlights that the product contains two medicines and is marketed as a pain reliever. The package contains 72 caplets and is labeled by Target Corporation under the up & up brand. The label includes warnings about liver damage and NSAID risks, along with usage instructions and contact information.*
FDA Label Image

716r_target Ibupara 72ct_ifc (716r Target Ibupara 72ct Ifc)

716r_target Ibupara 72ct_ifc (716r Target Ibupara 72ct Ifc)
Packaging label for Dual Action Pain Relief tablets containing Acetaminophen and Ibuprofen, NSAID tablets with 250 mg Acetaminophen and 125 mg Ibuprofen per caplet. The box contains 72 caplets and is distributed by Target Corporation. It features dosage and drug facts panels, warnings, and product identification details on a dark blue background with red and white text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.